Navigation Links
Silencing signals sent by parasite could aid sleeping sickness fight

A new discovery by scientists could help combat the spread of sleeping sickness.

Insights into how the parasites that cause the disease are able to communicate with one another could help limit the spread of the infection.

The findings suggest that new drugs could be designed to disrupt the flow of messages sent between these infectious microorganisms.

Sleeping sickness so named because it disrupts sleep patterns is transmitted by the bite of the tsetse fly, and more than 69 million people in Africa are at risk of infection. Untreated, it can damage the nervous system, leading to coma, organ failure and death.

During infection, the parasites known as African trypanosomes multiply in the bloodstream and communicate with each other by releasing a small molecule. When levels of this molecule become sufficiently high, this acts as a signal for the parasites to stop replicating and to change into a form that can be picked up by biting flies and spread.

A team led by researchers at the University of Edinburgh were able to uncover key components of the parasites' messaging system. They used a technique known as gene silencing, to identify those genes that are used to respond to the communication signals and the mechanisms involved.

Professor Keith Matthews, of the University of Edinburgh's School of Biological Sciences, who led the research, said: "Parasites are adept at communicating with one another to promote their survival in our bodies and ensure their spread but by manipulating their messages, new ways to combat these infections are likely to emerge."

The research, carried out in collaboration with the University of Dundee, was published in the journal Nature, and funded by the Wellcome Trust.


Contact: Catriona Kelly
University of Edinburgh

Page: 1

Related biology news :

1. Gene-silencing data now publicly available to help scientists better understand disease
2. Gene-silencing study finds new targets for Parkinsons disease
3. First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment
4. CSHL researchers solve structure of human protein critical for silencing genes
5. Plant research reveals new role for gene silencing protein
6. A powder to enhance NMR signals
7. How living cells solved a needle in a haystack problem to produce electrical signals
8. Artifact suppression and analysis of brain activities with EEG signals
9. Neurochemical traffic signals may open new avenues for the treatment of schizophrenia
10. Researchers discover a missing link in signals contributing to neurodegeneration
11. Social bees mark dangerous flowers with chemical signals
Post Your Comments:
Related Image:
Silencing signals sent by parasite could aid sleeping sickness fight
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
Breaking Biology Technology: